January 5, 2018 / 4:03 AM / a year ago

BRIEF-Tsh biopharm and Mycenax Biotech sign drug license rights transfer contract

Jan 5 (Reuters) - Tsh biopharm Corporation Ltd :

* Says Mycenax Biotech Inc and Tsh biopharm Corporation Ltd signed a license rights transfer contract for drug TuNEX, effective since Jan. 4

* Tsh biopharm will transfer drug licence and other relevant rights of drug TuNEX to Mycenax Biotech, and Mycenax Biotech will pay signing bonus, milestone payment and sales royalties to Tsh biopharm

Source text in Chinese: goo.gl/UYQq6B ; goo.gl/FBDsRa

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below